Your browser doesn't support javascript.
loading
Most breast cancer screening trials have a flawed design.
Gurnani, Nishant; Srivastava, Anurag.
Affiliation
  • Gurnani N; Department of Surgery, All India Institute of Medical Sciences, New Delhi, India.
Indian J Surg ; 73(6): 419-22, 2011 Dec.
Article in En | MEDLINE | ID: mdl-23204698
ABSTRACT
In the present article, we discuss that why most breast cancer screening trials have a flawed origin. We suggest some solutions to correct these flaws so that more valid and reliable screening trials can be conducted in the future.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Aspects: Patient_preference Language: En Journal: Indian J Surg Year: 2011 Document type: Article Affiliation country: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Aspects: Patient_preference Language: En Journal: Indian J Surg Year: 2011 Document type: Article Affiliation country: India